JP2023553534A5 - - Google Patents
Info
- Publication number
- JP2023553534A5 JP2023553534A5 JP2023560241A JP2023560241A JP2023553534A5 JP 2023553534 A5 JP2023553534 A5 JP 2023553534A5 JP 2023560241 A JP2023560241 A JP 2023560241A JP 2023560241 A JP2023560241 A JP 2023560241A JP 2023553534 A5 JP2023553534 A5 JP 2023553534A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- cancer
- composition according
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124669P | 2020-12-11 | 2020-12-11 | |
| US63/124,669 | 2020-12-11 | ||
| US202163214736P | 2021-06-24 | 2021-06-24 | |
| US63/214,736 | 2021-06-24 | ||
| US202163277555P | 2021-11-09 | 2021-11-09 | |
| US63/277,555 | 2021-11-09 | ||
| US202163283035P | 2021-11-24 | 2021-11-24 | |
| US63/283,035 | 2021-11-24 | ||
| PCT/US2021/062927 WO2022125971A1 (en) | 2020-12-11 | 2021-12-10 | Combination therapies for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553534A JP2023553534A (ja) | 2023-12-21 |
| JP2023553534A5 true JP2023553534A5 (enExample) | 2024-12-17 |
Family
ID=81974015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560241A Pending JP2023553534A (ja) | 2020-12-11 | 2021-12-10 | 癌の処置のための併用療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250195533A1 (enExample) |
| EP (1) | EP4259639A4 (enExample) |
| JP (1) | JP2023553534A (enExample) |
| KR (1) | KR20230151981A (enExample) |
| AU (1) | AU2021397319A1 (enExample) |
| CA (1) | CA3201612A1 (enExample) |
| WO (1) | WO2022125971A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12122787B2 (en) | 2019-09-20 | 2024-10-22 | Shanghai Jemincare Pharmaceuticals Co., Ltd | Fused pyridone compound, and preparation method therefor and use thereof |
| US20240293422A1 (en) * | 2021-06-24 | 2024-09-05 | Erasca, Inc. | Shp2 and cdk4/6 inhibitors combination therapies for the treatment of cancer |
| TW202322809A (zh) * | 2021-10-06 | 2023-06-16 | 美商艾瑞斯卡公司 | 三取代雜芳基衍生物作為src同源-2磷酸酶抑制劑之用途 |
| EP4426303B1 (en) * | 2021-11-02 | 2025-10-08 | Semmelweis Egyetem | Farnesyl-transferase inhibitors and kras inhibitors for treating kras mutant cancers |
| IL318882A (en) * | 2022-08-19 | 2025-04-01 | Mirati Therapeutics Inc | Solid pharmaceutical preparations of Adagrasib |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014206344A1 (en) * | 2013-06-28 | 2014-12-31 | Beigene, Ltd. | Fused tricyclic amide compounds as multiple kinase inhibitors |
| UA127968C2 (uk) * | 2017-05-22 | 2024-02-28 | Емджен Інк. | Інгібітори g12c kras і способи їх застосування |
| JP7337174B2 (ja) * | 2018-09-18 | 2023-09-01 | ニカング セラピューティクス， インコーポレイテッド | Ｓｒｃホモロジー－２ホスファターゼ阻害剤としての三置換ヘテロアリール誘導体 |
| JP7377679B2 (ja) * | 2018-11-19 | 2023-11-10 | アムジエン・インコーポレーテツド | がん治療のためのｋｒａｓｇ１２ｃ阻害剤及び１種以上の薬学的に活性な追加の薬剤を含む併用療法 |
| US12377101B2 (en) * | 2018-12-05 | 2025-08-05 | Mirati Therapeutics, Inc. | Combination therapies |
| CN113382774A (zh) * | 2019-02-12 | 2021-09-10 | 诺华股份有限公司 | 包含tno155和krasg12c抑制剂的药物组合 |
| EP4259147A4 (en) * | 2020-12-11 | 2024-10-23 | Erasca, Inc. | Combination therapies for the treatment of cancer |
| KR20230152652A (ko) * | 2020-12-11 | 2023-11-03 | 에라스카, 아이엔씨. | 암 치료를 위한 병용 요법 |
| US20240293422A1 (en) * | 2021-06-24 | 2024-09-05 | Erasca, Inc. | Shp2 and cdk4/6 inhibitors combination therapies for the treatment of cancer |
-
2021
- 2021-12-10 US US18/256,091 patent/US20250195533A1/en not_active Abandoned
- 2021-12-10 CA CA3201612A patent/CA3201612A1/en active Pending
- 2021-12-10 AU AU2021397319A patent/AU2021397319A1/en not_active Abandoned
- 2021-12-10 KR KR1020237023425A patent/KR20230151981A/ko not_active Abandoned
- 2021-12-10 EP EP21904514.3A patent/EP4259639A4/en not_active Withdrawn
- 2021-12-10 WO PCT/US2021/062927 patent/WO2022125971A1/en not_active Ceased
- 2021-12-10 JP JP2023560241A patent/JP2023553534A/ja active Pending